Search research articles
Contact Us
Filters
Showing results (111-120 of 283) with videos related to
Page
of 29
Sort By:
American Journal of Public Health
|
November 15, 2008
Substance abuse and hospitalization for mood disorder among Medicaid beneficiaries
Jonathan D Prince, Ayse Akincigil, Donald R Hoover, et al.
Pediatrics
|
May 30, 2012
Treatment of maladaptive aggression in youth: CERT guidelines II. Treatments and ongoing management
Nancy Scotto Rosato, Christoph U Correll, Elizabeth Pappadopulos, et al.
Journal of Substance Abuse Treatment
|
June 7, 2021
Perspectives of opioid use disorder treatment providers during COVID-19: Adapting to flexibilities and sustaining reforms
Peter C Treitler, Cadence F Bowden, James Lloyd, et al.
Health Services Research
|
December 28, 2020
A best-worst scaling experiment to identify patient-centered claims-based outcomes for evaluation of pediatric antipsychotic monitoring programs
Thomas I Mackie, Katherine M Kovacs, Cassandra Simmel, et al.
JAMA Network Open
|
February 18, 2026
Medicaid Expansion and Buprenorphine Dispensing in Early vs Recent Expansion States
Nicole Siegal, Sumedha Gupta, Jennifer Miles, et al.
AIDS and Behavior
|
April 13, 2011
Antidepressant treatment and adherence to antiretroviral medications among privately insured persons with HIV/AIDS
Ayse Akincigil, Ira B Wilson, James T Walkup, et al.
The Journal of Clinical Psychiatry
|
July 8, 2017
Antipsychotic Medication Treatment Patterns in Adult Depression
Tobias Gerhard, T Scott Stroup, Christoph U Correll, et al.
Health Affairs (Project Hope)
|
June 9, 2016
Rapid Growth Of Antipsychotic Prescriptions For Children Who Are Publicly Insured Has Ceased, But Concerns Remain
Stephen Crystal, Thomas Mackie, Miriam C Fenton, et al.
General Hospital Psychiatry
|
December 7, 2023
Suicide within 1 year of non-fatal overdose: Risk factors and risk reduction with medications for opioid use disorder
Molly A Nowels, Paul R Duberstein, Stephen Crystal, et al.
The American Journal of Psychiatry
|
May 6, 2024
Defining Discontinuation for Buprenorphine Treatment: Implications for Quality Measurement
Arthur Robin Williams, Christine M Mauro, Ben Huber, et al.
Page
of 29
Search research articles
Search
Showing results (111-120 of 283) with videos related to
Sort By:
Page
of 29
American Journal of Public Health
|
November 15, 2008
Substance abuse and hospitalization for mood disorder among Medicaid beneficiaries
Jonathan D Prince, Ayse Akincigil, Donald R Hoover, et al.
Pediatrics
|
May 30, 2012
Treatment of maladaptive aggression in youth: CERT guidelines II. Treatments and ongoing management
Nancy Scotto Rosato, Christoph U Correll, Elizabeth Pappadopulos, et al.
Journal of Substance Abuse Treatment
|
June 7, 2021
Perspectives of opioid use disorder treatment providers during COVID-19: Adapting to flexibilities and sustaining reforms
Peter C Treitler, Cadence F Bowden, James Lloyd, et al.
Health Services Research
|
December 28, 2020
A best-worst scaling experiment to identify patient-centered claims-based outcomes for evaluation of pediatric antipsychotic monitoring programs
Thomas I Mackie, Katherine M Kovacs, Cassandra Simmel, et al.
JAMA Network Open
|
February 18, 2026
Medicaid Expansion and Buprenorphine Dispensing in Early vs Recent Expansion States
Nicole Siegal, Sumedha Gupta, Jennifer Miles, et al.
AIDS and Behavior
|
April 13, 2011
Antidepressant treatment and adherence to antiretroviral medications among privately insured persons with HIV/AIDS
Ayse Akincigil, Ira B Wilson, James T Walkup, et al.
The Journal of Clinical Psychiatry
|
July 8, 2017
Antipsychotic Medication Treatment Patterns in Adult Depression
Tobias Gerhard, T Scott Stroup, Christoph U Correll, et al.
Health Affairs (Project Hope)
|
June 9, 2016
Rapid Growth Of Antipsychotic Prescriptions For Children Who Are Publicly Insured Has Ceased, But Concerns Remain
Stephen Crystal, Thomas Mackie, Miriam C Fenton, et al.
General Hospital Psychiatry
|
December 7, 2023
Suicide within 1 year of non-fatal overdose: Risk factors and risk reduction with medications for opioid use disorder
Molly A Nowels, Paul R Duberstein, Stephen Crystal, et al.
The American Journal of Psychiatry
|
May 6, 2024
Defining Discontinuation for Buprenorphine Treatment: Implications for Quality Measurement
Arthur Robin Williams, Christine M Mauro, Ben Huber, et al.
Page
of 29